Diagnosis and Therapy of Organ Dysfunction Using Sphinganine-1-phosphate
The invention relates to the treatment and diagnosis of organ dysfunction caused by ischemia reperfusion injury. In particular, the invention relates to sphinganine-1-phosphate, a sphingolipid metabolite, and its use in the diagnosing, preventing, and/or treating ischemia reperfusion-associated disorders, including, without limitation, disorders of the kidney, liver, lung, brain, and heart.
LEE THOMAS H [US]; KIM MIHWA [US]
Type of Offer:
« More Diagnostic Patents